![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/cyrano-therapeutics-secures-9-0-million-series-b-financing-to-advance-clinical-development-of-cyr-064-for-treatment-of-post-viral-smell-loss-302031744.html
https://www.prnewswire.com/news-releases/cyrano-therapeutics-enrolls-first-patient-in-phase-2-trial-of-cyr-064-for-post-viral-smell-loss-hyposmia-301954527.html
https://www.clinicaltrialsarena.com/news/cyrano-trial-nasal-spray-therapy-hyposmia/
https://www.prnewswire.com/news-releases/cyrano-therapeutics-announces-the-appointment-of-john-kollins-to-its-board-of-directors-301420237.html